Methodologic issues in the validation of putative biomarkers and surrogate endpoints in treatment evaluation for systemic lupus erythematosus (Q37101364)

From Wikidata
Jump to navigation Jump to search
scientific article published on March 2009
edit
Language Label Description Also known as
English
Methodologic issues in the validation of putative biomarkers and surrogate endpoints in treatment evaluation for systemic lupus erythematosus
scientific article published on March 2009

    Statements

    Methodologic issues in the validation of putative biomarkers and surrogate endpoints in treatment evaluation for systemic lupus erythematosus (English)
    Matthew H Liang
    Benjamin T Dore
    Michael Ward
    Paul R Fortin
    Gabor G Illei
    Barbara Mittleman
    Jill Buyon
    Samardeep Gupta
    1 March 2009
    108-112

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit